Literature DB >> 1310644

Case report: arachnoiditis following intracranial 'Thorotrast'.

P M Pandya1, A J Keogh.   

Abstract

A patient is reported with a painless, progressive cauda equina lesion due to arachnoiditis, the result of the contrast medium 'Thorotrast' (thorium dioxide) introduced into the brain over 30 years previously. Contrast medium introduced into the lumbar spine can give rise to aseptic adhesive inflammation (arachnoiditis). It rarely gives rise to clinical problems but, when it does so, is usually associated with back pain and only very rarely with progressive neurological deficit.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310644     DOI: 10.1016/s0009-9260(05)80074-1

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  Intermittent diplopia and strabismus caused by ocular neuromyotonia.

Authors:  R D Yee; V A Purvin; B Azzarelli; P B Nelson
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 2.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

3.  Chronic alpha-irradiation of the nervous system from thorium dioxide.

Authors:  E H Jellinek
Journal:  J R Soc Med       Date:  2004-07       Impact factor: 18.000

4.  Hidden genetic variation shapes the structure of functional elements in Drosophila.

Authors:  Mahul Chakraborty; Nicholas W VanKuren; Roy Zhao; Xinwen Zhang; Shannon Kalsow; J J Emerson
Journal:  Nat Genet       Date:  2017-12-18       Impact factor: 38.330

Review 5.  The population genetics of crypsis in vertebrates: recent insights from mice, hares, and lizards.

Authors:  Rebecca B Harris; Kristen Irwin; Matthew R Jones; Stefan Laurent; Rowan D H Barrett; Michael W Nachman; Jeffrey M Good; Catherine R Linnen; Jeffrey D Jensen; Susanne P Pfeifer
Journal:  Heredity (Edinb)       Date:  2019-08-09       Impact factor: 3.821

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.